Qiagen, Maverix Biomics Ink Informatics Co-Marketing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Maverix Biomics announced today that it has signed a non-exclusive co-marketing agreement with Qiagen to integrate the Maverix Analytic platform with Qiagen's Ingenuity iReport biological data interpretation solution.

According to the company, its platform will complement Qiagen's sample-to-insight workflow by providing easy, three-step, push-button data analysis that includes tools for genome alignment that will help researchers obtain biological meaning from expression data and better understand what may impact disease pathways.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.